Australia markets close in 2 hours 57 minutes

FIBROBIOLOGICS INC. (SG0.BE)

Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
10.60-0.30 (-2.75%)
At close: 08:08PM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
Total revenue
0
0
0
0
Operating expenses
Research development
2,850
2,368
1,147
521
Selling general and administrative
7,224
6,521
3,320
1,057
Total operating expenses
10,074
8,889
4,467
1,578
Operating income or loss
-10,074
-8,889
-4,467
-1,578
Interest expense
16
147
654
4
Total other income/expenses net
-12,479
-7,449
-
-
Income before tax
-22,530
-16,485
-5,121
-1,582
Income from continuing operations
-22,530
-16,485
-5,121
-1,582
Net income
-22,530
-16,485
-5,121
-1,582
Net income available to common shareholders
-22,530
-19,058
-5,121
-1,582
Basic EPS
-0.59
-0.59
-0.16
-0.05
Diluted EPS
-0.59
-0.59
-0.16
-0.05
Basic average shares
32,492
32,492
32,477
32,477
Diluted average shares
32,492
32,492
32,477
32,477